hun mo ryoo

Continuous infusion of intermediate‐dose cytarabine and fludarabine with idarubicin for patients younger than 60 years with resistant acute myeloid leukemia: A prospective, multicenter phase II study

W. Lee, Y. Joo, Je-Hwan Lee, 2009, American journal of hematology.